Belenos Biosciences is a clinical-stage biotechnology company focused on developing next-generation, long-acting bispecific antibody therapeutics to transform the treatment of chronic inflammatory diseases
Belenos Biosciences is a clinical-stage biotechnology company focused on developing next-generation, long-acting bispecific antibody therapeutics to transform the treatment of chronic inflammatory diseases. The company aims to make clinical remission the standard of care for conditions such as asthma, chronic obstructive pulmonary disease (COPD), and atopic dermatitis.